Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Clinical trial NCT00560963 · COMPLETED

Trial details

NCT number: NCT00560963
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Pancreatic Adenocarcinoma

Start date: 2007-10-01
Primary completion: 2011-01-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.